|Bid||4.7500 x 28000|
|Ask||4.7000 x 1800|
|Day's range||4.3000 - 4.6000|
|52-week range||1.9400 - 10.8900|
|Beta (5Y monthly)||1.10|
|PE ratio (TTM)||15.08|
|Earnings date||04 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||6.17|
Endo (ENDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Endo (ENDP) stock gains following the settlement of three opioid cases in the New York State in exchange for a total payment of $50 million.
Investors need to pay close attention to Endo International (ENDP) stock based on the movements in the options market lately.